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ObituaryDonald Metcalf (1929–2014)Once more unto the breach, dear
friends, once more,Or close the wall up with our
English dead!In peace there’s nothing so be-
comes a manAs modest stillness and humility,
But when the blast of war blows in
our ears,Then imitate the action of the tiger:
Stiffen the sinews, summon up the
blood.
—William Shakespeare
(King Henry, Henry V)
Donald Metcalf—Professor Metcalf to
those younger colleagues who were
meeting him for the first time and Don to
everyone else—was one of the fathers of
modern hematology, shaping the field
for the 60 years of his working life (1954–
2014) at TheWalter and Eliza Hall Institute
of Medical Research.
Don was born in Mittagong, Australia,
a little more than 100 km southwest of
Sydney, on February 26, 1929, just prior
to the start of the depression. Don’s
parents were schoolteachers, and his
childhood was nomadic, moving with
them from school to school in countryDonald MetcalfNew South Wales. As one
might expect, this environ-
ment instilled the self-reliance,
resilience, work ethic, and
appreciation for education
that characterized Don’s
entire life. Following school,
Don entered Sydney Univer-
sity as a medical student
in 1946 and completed a
research year in the laboratory
of Pat De Burgh, working on
ectromelia virus. That year
of research whetted Don’s
appetite, and after graduating
in 1953, Don was awarded the
Carden Fellowship of the Anti-
Cancer Council of Victoria
and moved to Melbourne in
1954 to establish a cancer
research laboratory at The
Walter and Eliza Hall Institute
of Medical Research, which
was at that time led by thefuture Nobel Laureate Frank McFarlane
Burnet.
In an age when scientific superstars run
mega-labs and often move from institu-
tion to institution chasing ever more lucra-
tive packages, the opposite was true of
Don. Throughout his entire career, he
was supported by the same fellowship
and worked at the same institution.
Despite his burgeoning reputation, he
never left the laboratory bench and con-
ducted experiments himself with the sup-
port of one or two research assistants and
an occasional graduate student. Having
studied thymus development and lym-
phomagenesis for a decade, Don’s epiph-
any came in 1965, when with Ray Bradley
at The University of Melbourne, he used
semi-solid culture medium containing a
crude source of growth factor to grow col-
onies of granulocytes and macrophages
from their precursors in the bone marrow.
Don realized immediately that this tech-
nique would not only permit him to map
the hierarchical relationship between
multipotential stem cells, committed pro-
genitors, and their differentiating progeny,
but would also allow him to define the hor-
mones that regulated the process. Don
worked on nothing else for the nextCell 16050 years and, in doing so, made the blood
cell system the poster child for under-
standing tissue renewal.
Don named the hormones that stimu-
lated the growth of blood cells colony-
stimulating factors, or CSFs. Unlike
classic hormones, which are produced
by a single tissue or cell type and act
widely, Don found CSFs to be produced
by almost every tissue he examined, but
in vanishingly small amounts, and to act
on a limited set of target cells. This re-
sulted in a huge degree of skepticism in
the scientific community; many thought
that CSFs were in vitro artifacts that
were of little importance to the regulation
of blood cell production in vivo. Skepti-
cism was the spur that Don relished. Re-
cruiting a series of protein chemists and
molecular biologists to the collaborative
cause, including Richard Stanley, Tony
Burgess, Nicos Nicola, Ashley Dunn, and
Nick Gough, Don orchestrated a 30-year
collaboration that saw the purification to
homogeneity of four colony-stimulating
factors: granulocyte CSF (G-CSF),
macrophage CSF (M-CSF), granulocyte-
macrophage CSF (GM-CSF), and multi-
CSF, which is now better known as inter-
leukin-3., January 29Thepurification of theCSFs
led to the cloning of their
genes—GM-CSF by Don’s
team in Melbourne and
G-CSF, M-CSF, and IL-3 by
others—and ultimately led to
the mass production of
CSFs, allowing Don to do the
experiment about which he
had dreamed for 30 years:
injecting pure recombinant
CSFs into animals and seeing
whether blood cell produc-
tion becomes elevated. The
answer was an emphatic
yes, and these in vivo experi-
ments paved the way for the
successful use of G-CSF and
GM-CSF in elevating the level
of white cells in patients un-
dergoing chemotherapy for
cancer to reduce the likeli-
hood of infection due to
leukopenia. It was during, 2015 ª2015 Elsevier Inc. 361
these clinical trials that Don and a post-
doctoral fellow, Uli Du¨hrsen, discovered
that, upon injection of patients with
G-CSF, stem cells migrated from the
bone marrow into the peripheral blood.
This observation rapidly led to the use of
G-CSF as an agent to mobilize stem cells,
meaning that they could be obtained by
simple blood collection rather than the
more complicated and painful bone
marrow harvest. This revolutionized bone
marrow transplantation, making it safer,
more effective, and more broadly appli-
cable. It is estimated that more than
20 million people have benefitted from
Don’s discoveries, including the Spanish
tenor Jose´ Carreras, who was an early
recipient of the therapy.
Don’s profound discoveries led to
countless distinguished lectureships,
awards, and prizes, including Fellowship
of the Australian Academy of Science,
The Royal Society and the US National
Academy of Sciences, The Bristol-Myers
Award for Distinguished Achievement in
Cancer Research, The Robert Koch Prize,
The Armand Hammer Prize for Cancer
Research, The General Motors Cancer
Foundation Sloan Prize, The Lasker-De-
Bakey Clinical Medical Research Award,
and a Lifetime Achievement Award from
the American Association for Cancer
Research. Although his profound discov-
eries and many honors epitomize the sci-
entist, they don’t paint a complete picture
of the man.
Don detested spin—he wanted his data
to speak for itself and was scathing of re-
searchers he termed ‘‘prancers’’ or ‘‘strut-
ters,’’ who were more showmen than sci-362 Cell 160, January 29, 2015 ª2015 Elsevieentists. At conferences and in seminars,
he would ask the incisive question or, if
required, deliver the acerbic assess-
ment—the more famous the researcher,
themore pointed and colorful the criticism
if the talk was not up to par. He was happy
to send his papers to specialty hematolo-
gy journals, and unless badgered by
ambitious junior colleagues, Don es-
chewed what he called ‘‘fancy’’ journals,
which he thought required sensationaliza-
tion of the story.
Don was comfortable working in Mel-
bourne, which for those in Boston, San
Francisco, London, or Paris seemed like
the end of the Earth. This tyranny of dis-
tance was actually a great source of com-
fort to Don, who could follow his own
scientific compass without being blown
off course by trends or fads. Don was
deeply suspicious of researchers who,
on achieving a level of success, retreated
out of the laboratory into the safety of their
office. He was a man who led from the
experimental front for his whole life, which
is why he so liked the ‘‘Once more unto
the breach’’ speech of Henry V and titled
his autobiography Summon Up The
Blood. He worked five and a half days a
week for most of the last 50 years, with
his only concession to age being an
occasional Saturday off and leaving
work a little early to avoid the traffic in
the evening.
Other than a bad back, which was no
doubt exacerbated by endless hours
working at themicroscope, Don remained
in remarkable health until the middle of
last year. Feeling ‘‘off color,’’ Don and
his beloved wife of 60 years, Josephine,r Inc.took a vacation, which he hoped would
reinvigorate him for another decade of
discovery. Returning in August feeling
worse, Don suspected the worst and
was quickly diagnosed with metastatic
pancreatic cancer. Knowing the chance
of cure was slim, Don had two concerns:
to finish off the experiments awaiting his
return from vacation and to spend as
much time as possible with his family.
But how to do both? The answer was to
have his microscope moved from his lab-
oratory to his dining room table at home
and to do experiments when his chemo-
therapy schedule allowed. Don carried
out his last experiment in November,
when his health began to decline precipi-
tously. He died on December 15, 2014,
surrounded by his wife Jo and their four
daughters and their families. Don was an
experimentalist and a family man to the
end. He would have wanted it no other
way.
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